External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population

BACKGROUND & AIMS: The Toronto hepatocellular carcinoma (HCC) risk index (THRI) is a predictive model to determine the risk of HCC in patients with cirrhosis. This study aimed to externally validate the THRI in a Swedish setting to investigate whether it could identify patients not requiring HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Åström, Hanne, Ndegwa, Nelson, Hagström, Hannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476346/
https://www.ncbi.nlm.nih.gov/pubmed/34611618
http://dx.doi.org/10.1016/j.jhepr.2021.100343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476346/
https://www.ncbi.nlm.nih.gov/pubmed/34611618
http://dx.doi.org/10.1016/j.jhepr.2021.100343

Ejemplares similares